The main aim of the present study is to investigate whether intranasal vasopressin (20IU)
      could influence attention control in a social-emotional saccade/antisaccade eye-tracking
      paradigm.

The Effects of Vasopressin on Attention Control

Healthy

A number of previous studies have reported vasopressin's effect on human social behavior and
      social cognition, although it remains unclear whether vasopressin could modulate attention
      allocation including stimulus-driven bottom-up control and goal-directed top-down control. In
      the current randomized, between-subject, placebo controlled study, 89 healthy male subjects
      will be recruited and receive either vasopressin (20 IU) or placebo control administered
      intranasally. 45 minutes after treatment subjects will be required to complete a
      social-emotional saccade /antisaccade eye-tracking paradigm. The paradigm uses social (happy,
      sad, angry, fear, and neutral faces) as well as non-social (oval shapes) stimuli to explore
      social- and emotion-specific effects of vasopressin.

Vasopressin

Placebo

The Effects of Vasopressin on Attention Control: An Eye-tracking Study

Comparison between social-specific saccade/antisaccade latencies (in milliseconds) between the vasopressin and placebo treatment conditions

Comparison between social-specific error rates of saccade/antisaccade between the vasopressin and placebo treatment conditions

Professor

Comparison between emotion-specific saccade/antisaccade latencies (in milliseconds) between the vasopressin and placebo treatment conditions

Comparison between emotion-specific saccade/antisaccade error rates between the vasopressin and placebo treatment conditions

The Effects of Vasopressin on Attention Control

About this trial

Study ID

Status

Type

Phase

Placebo

Accepting

Trial Timing

What is this trial about?

What are the participation requirements?

Locations

Location

Status